Related Experiment Videos
Scorecards: a new method to prevent adverse drug events? Preliminary results from a clinical field study
Romaric Marcilly1, Werner O Hackl, Michel Luyckx
1INSERM CIC-IT Evalab, CHU Lille, UDSL EA2694, Univ Lille Nord de France, F-59000 Lille, France. romaric.marcilly@univ-lille2.fr
Abstract:
In the field of the detection and prevention of preventable ADEs, several methods have been explored to decrease the rate of ADEs due to monitoring errors. This paper describes an innovative method that aims at improving patient safety by increasing ADEs' awareness of healthcare professionals. To this end, ADE-scorecards that provide healthcare professionals with retrospective data about ADEs' causes and rates have been developed. In order to evaluate the impact of this method on the ADE rate, in-field clinical tests have been set up. Data were collected by both qualitative (semi-structured interviews) and quantitative methods (log analysis and ADE rate calculation). Preliminary results reveal that ADE-scorecards are well-accepted by most of the healthcare professionals who intend to use them as discussion supports and/or learning tools. Thus, ADE-scorecards seem to be a relevant method to improve patient safety by increasing ADE-awareness of healthcare professionals.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blind Procedures
Clinical Trials: Overview